UK BMT Pharmacists Group Educational Meeting Series | UK BMT Pharmacists Group Educational Meeting Series (November 2022)
Session 2: Clinical updates on the management of Graft Versus Host Disease / Ruxolitinib for steroid-refractory Graft Versus Host Disease- Results of National UK Audit (November 2022)
You do not have access to this area. Please contact a website administrator if this is incorrect.
UK BMT Pharmacists Group Educational Meeting Series Resources
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.
